Neuroinflammation in bipolar disorder - A [11C]-(R)-PK11195 positron emission tomography study

Brain, Behavior, and Immunity

Volumn 40, Issue , 2014, Pages 219-225

  Haarman, Bartholomeus C M Benno ^a   Riemersma Van der Lek, Rixt F ^a   de Groot, Jan Cees ^a   Ruhé, Henricus G Eric ^a   Klein, Hans C ^a   Zandstra, Tjitske E ^a   Burger, Huibert ^a   Schoevers, Robert A ^a   de Vries, Erik F J ^a   Drexhage, Hemmo A ^b   Nolen, Willem A ^a   Doorduin, Janine ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Bipolar disorder; Microglia; Neuroinflammation; PET

Indexed keywords

CARBON 11; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; CARBON; ISOQUINOLINE DERIVATIVE;

ADULT; AGED; ARTICLE; BIPOLAR I DISORDER; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; MICROGLIA; MIDDLE AGED; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ONSET AGE; POSITRON CAMERA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; YOUNG ADULT; YOUNG MANIA RATING SCALE; BIPOLAR DISORDER; ENCEPHALITIS; IMMUNOLOGY; SCINTISCANNING;

ADULT; AGED; BIPOLAR DISORDER; CARBON RADIOISOTOPES; ENCEPHALITIS; FEMALE; HIPPOCAMPUS; HUMANS; ISOQUINOLINES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; YOUNG ADULT;

EID: 84904099243     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.03.016     Document Type: Article

References (51)

1. Aronica E., Crino P.B. Inflammation in epilepsy: clinical observations. Epilepsia 2011, 52(Suppl 3):26-32.
2. Banati R.B. Visualising microglial activation in vivo. Glia 2002, 40:206-217.
3. Benes F.M., Matzilevich D., Burke R.E., Walsh J. The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol. Psychiatry 2006, 11:241-251.
4. Beumer W., Gibney S.M., Drexhage R.C., Pont-Lezica L., Doorduin J., Klein H.C., Steiner J., Connor T.J., Harkin A., Versnel M.a., Drexhage H.a. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J. Leukoc. Biol. 2012, 92:1-17.
5. Brown E.S. Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann. N. Y. Acad. Sci. 2009, 1179:41-55.
6. Che Y., Wang J.-F., Shao L., Young T. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J. Psychiatry Neurosci. 2010, 35:296-302.
7. Choi J., Ifuku M., Noda M., Guilarte T.R. Translocator protein (18kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state. Glia 2011, 59:219-230.
8. Costello D.a., Lyons A., Denieffe S., Browne T.C., Cox F.F., Lynch M.a. Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: a role for Toll-like receptor activation. J. Biol. Chem. 2011, 286:34722-34732.
9. Deckersbach T., Dougherty D.D., Savage C., McMurrich S., Fischman A.J., Nierenberg A., Sachs G., Rauch S.L. Impaired recruitment of the dorsolateral prefrontal cortex and hippocampus during encoding in bipolar disorder. Biol. Psychiatry 2006, 59:138-146.
10. Deicken R.F., Pegues M.P., Anzalone S., Feiwell R., Soher B. Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder. Am. J. Psychiatry 2003, 160:873-882.
11. 11C-(R)-PK11195 and 18F-GE-180. J. Nucl. Med. 2014, 55:466-472.
12. Dobos N., de Vries E.F.J., Kema I.P., Patas K., Prins M., Nijholt I.M., Dierckx R.A., Korf J., den Boer J.A., Luiten P.G.M., Eisel U.L.M. The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J. Alzheimers Dis. 2012, 28:905-915.
13. Doorduin J., de Vries E.F.J., Dierckx R.A., Klein H.C. PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders. Curr. Pharm. Des. 2008, 14:3297-3315.
14. Doorduin J., de Vries E.F.J., Willemsen A.T.M., de Groot J.C., Dierckx R.a., Klein H.C. Neuroinflammation in schizophrenia-related psychosis: a PET study. J. Nucl. Med. 2009, 50:1801-1807.
15. Drzyzga L., Obuchowicz E., Marcinowska A., Herman Z.S. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav. Immun. 2006, 20:532-545.
16. Folkersma H., Boellaard R., Yaqub M., Kloet R.W., Windhorst A.D., Lammertsma A.a., Vandertop W.P., van Berckel B.N.M. Widespread and prolonged increase in (R)-(11)C-PK11195 binding after traumatic brain injury. J. Nucl. Med. 2011, 52:1235-1239.
17. Garvey L.J., Pavese N., Politis M., Ramlackhansingh A., Brooks D.J., Taylor-Robinson S.D., Winston A. Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS 2014, 28:67-72.
18. Gonul A.S., Coburn K., Kula M. Cerebral blood flow, metabolic, receptor, and transporter changes in bipolar disorder: the role of PET and SPECT studies. Int. Rev. Psychiatry 2009, 21:323-335.
19. Grover V.P.B., Pavese N., Koh S.-B., Wylezinska M., Saxby B.K., Gerhard a., Forton D.M., Brooks D.J., Thomas H.C., Taylor-Robinson S.D. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J. Viral Hepat. 2012, 19:89-96.
20. Haarman B.C., Riemersma-Van der Lek R.F., Burger H., Netkova M., Drexhage R.C., Bootsman F., Mesman E., Hillegers M.H., Spijker A.T., Hoencamp E., Drexhage H.a., Nolen W.a. Relationship between clinical features and inflammation-related monocyte gene expression in bipolar disorder - towards a better understanding of psychoimmunological interactions. Bipolar Disord. 2013, 1-14.
21. 11C]PBR28 PET study. Brain Behav. Immun. 2013, 33:131-138.
22. Hochberg Y., Benjamini Y. More powerful procedures for multiple significance testing. Stat. Med. 1990, 9:811-818.
23. Hostenbach S., Cambron M., D'haeseleer M., Kooijman R., De Keyser J. Astrocyte loss and astrogliosis in neuroinflammatory disorders. Neurosci. Lett. 2013, 10-12.
24. Kato N., Nemoto K., Arino H., Fujikawa K. Influence of peripheral inflammation on growth-associated phosphoprotein (GAP-43) expression in dorsal root ganglia and on nerve recovery after crush injury. Neurosci. Res. 2003, 45:297-303.
25. Kreisel T., Frank M.G., Licht T., Reshef R., Ben-Menachem-Zidon O., Baratta M.V., Maier S.F., Yirmiya R. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol. Psychiatry 2013, 1-11.
26. Kreisl W.C., Jenko K.J., Hines C.S., Lyoo C.H., Corona W., Morse C.L., Zoghbi S.S., Hyde T., Kleinman J.E., Pike V.W., McMahon F.J., Innis R.B. A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J. Cereb. Blood Flow Metab. 2013, 33:53-58.
27. Lavisse S., Guillermier M., Hérard A.-S., Petit F., Delahaye M., Van Camp N., Ben Haim L., Lebon V., Remy P., Dollé F., Delzescaux T., Bonvento G., Hantraye P., Escartin C. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J. Neurosci. 2012, 32:10809-10818.
28. Leverich G.S., Nolen W.A., Rush A.J., McElroy S.L., Keck P.E., Denicoff K.D., Suppes T., Altshuler L.L., Kupka R., Kramlinger K.G., Post R.M. The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J. Affect. Disord. 2001, 67:33-44.
29. Macchi F., Homberg J.R., Calabrese F., Zecchillo C., Racagni G., Riva M.a., Molteni R. Altered inflammatory responsiveness in serotonin transporter mutant rats. J. Neuroinflammation 2013, 10:116.
30. Maes M., Smith R., Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 1995, 20:111-116.
31. Marazziti D., Dell'Osso B., Baroni S., Masala I., Di Nasso E., Giannaccini G., Dell'Osso L. Changes in peripheral benzodiazepine receptors in patients with bipolar disorder. Neuropsychiatr. Dis. Treat. 2005, 1:151-154.
32. MOODINFLAME website (2014):. http://moodinflame.eu.
33. Myint A.M., Kim Y.-K., Verkerk R., Park S.H., Scharpé S., Steinbusch H.W.M., Leonard B.E. Tryptophan breakdown pathway in bipolar mania. J. Affect. Disord. 2007, 102:65-72.
34. Padmos R.C., Hillegers M.H.J., Knijff E.M., Vonk R., Bouvy A., Staal F.J.T., de Ridder D., Kupka R.W., Nolen W.a., Drexhage H.a. A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Arch. Gen. Psychiatry 2008, 65:395-407.
35. Paolicelli R.C., Bolasco G., Pagani F., Maggi L., Scianni M., Panzanelli P., Giustetto M., Ferreira T.A., Guiducci E., Dumas L., Ragozzino D., Gross C.T. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333:1456-1458.
36. Pollmächer T., Haack M., Schuld A. Effects of antipsychotic drugs on cytokine networks. J. Psychiatr. 2000, 34:369-382.
37. Roumier A., Béchade C., Poncer J.-C., Smalla K.-H., Tomasello E., Vivier E., Gundelfinger E.D., Triller A., Bessis A. Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. J. Neurosci. 2004, 24:11421-11428.
38. Roumier A., Pascual O., Béchade C., Wakselman S., Poncer J.-C., Réal E., Triller A., Bessis A. Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function. PLoS One 2008, 3:e2595.
39. Rush A.J., Weissenburger J., Giles E., Schlesser M.A., Fulton C.L. The Inventory Preliminary for Depressive Findings Symptomatology (IDS). Depression 1986, 65-87.
40. Rybakowski J.K. Antiviral and immunomodulatory effect of lithium. Pharmacopsychiatry 2000, 33:159-164.
41. Savitz J., Frank M.B., Victor T., Bebak M., Marino J.H., Bellgowan P.S.F., McKinney B.A., Bodurka J., Kent Teague T., Drevets W.C. Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities. Brain Behav. Immun. 2013, 31:161-171.
42. Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., Ransohoff R.M., Greenberg M.E., Barres B.a., Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705.
43. Schulze T.G. Genetic research into bipolar disorder: the need for a research framework that integrates sophisticated molecular biology and clinically informed phenotype characterization. Psychiatr. Clin. North Am. 2010, 33:67-82.
44. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl 2):22-33. quiz 34-57.
45. Sierra A., Encinas J.M., Deudero J.J.P., Chancey J.H., Enikolopov G., Overstreet-Wadiche L.S., Tsirka S.E., Maletic-Savatic M. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 2010, 7:483-495.
46. Svarer C., Madsen K., Hasselbalch S.G., Pinborg L.H., Haugbøl S., Frøkjaer V.G., Holm S., Paulson O.B., Knudsen G.M. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 2005, 24:969-979.
47. Tian S.Y., Wang J.-F., Bezchlibnyk Y.B., Young L.T. Immunoreactivity of 43kDa growth-associated protein is decreased in post mortem hippocampus of bipolar disorder and schizophrenia. Neurosci. Lett. 2007, 411:123-127.
48. 11C]PK11195 positron emission tomography study. Biol. Psychiatry 2008, 64:820-822.
49. Vargas C., López-Jaramillo C., Vieta E. A systematic literature review of resting state network-functional MRI in bipolar disorder. J. Affect. Disord. 2013, 150:727-735.
50. Wiley C.a., Lopresti B.J., Becker J.T., Boada F., Lopez O.L., Mellors J., Meltzer C.C., Wisniewski S.R., Mathis C.a. Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment. J. Neurovirol. 2006, 12:262-271.
51. Young R.C., Biggs J.T., Ziegler V.E., Meyer D.a. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978, 133:429-435. publication.